ArticleThe Journal of clinical investigation2024

Targeting aryl hydrocarbon receptor functionally restores tolerogenic dendritic cells derived from patients with multiple sclerosis.

Federico Fondelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.